February 11, 2025
Breakthrough T1D Announces National Volunteer Award Recipients at Annual One Conference
February 9, 2025
Statement from Aaron J. Kowalski, PhD, CEO of Breakthrough T1D, Formerly JDRF, the Leading Global Type 1 Diabetes Research and Advocacy Organization, on NIH Indirect Costs Cuts
February 5, 2025
Breakthrough T1D Celebrates Supreme Court Justice Sonia Sotomayor at the World Premiere of Just Ask!
January 7, 2025
Sana Biotechnology Announces Positive Clinical Results from Type 1 Diabetes Study of Islet Cell Transplantation Without Immunosuppression
December 21, 2024
Breakthrough T1D, the Leading Global Type 1 Diabetes Research and Advocacy Organization, Expresses Gratitude for Extension of Special Diabetes Program
December 11, 2024
Breakthrough T1D and the Manning Family Foundation Unite Emerging Investigators and Leaders in Science, Industry, and Academia to Advance Type 1 Diabetes Research in Charlottesville, Virginia
November 22, 2024
Breakthrough T1D, Formerly JDRF, Statement on FDA Decision Not to Approve Zynquista (sotagliflozin) for Glucose Control in People with Type 1 Diabetes and Chronic Kidney Disease
November 18, 2024
Breakthrough T1D Applauds Senate Diabetes Caucus Co-Chairs for Leading Bipartisan Letter of Support for Special Diabetes Program
November 15, 2024
Breakthrough T1D Leads Effort to Make Screening for T1D Part of Recommended Preventive Services in the US
November 14, 2024
